Abstract:Background: Epidemiological and cytological studies have found a potential protective function of Vitamin D3 in colitis-associated colorectal cancer (CAC). In this study, we aim to decipher this effect in an azoxymethane (AOM) and dextran sulfate sodium (DSS) induced CAC mouse model and explore the underlying mechanism primarily focusing on the β-catenin signaling pathway. Methods: In vitro, colon cancer cell line SW480 were treated with 1,25(OH)2D3 at different concentrations (1, 10, 50 and 100nmol/L) for 24, 48 and 72h and then quantified for proliferation. Transcriptional activity and the protein level of β-catenin were determined in SW480 cells both nontreated (control) and treated with 100nmol/L 1,25(OH)2D3 for 48h. Same assay was applied to SW480 cells with FOXM1 and nVDR siRNA knockdowns separately. In animal experiment, C57BL/6 mice were divided into 6 groups. Group 1 was the naïve control given only saline. Group 2 to 6 were given AOM (12.5mg/kg) by intraperitoneal injection and 2.5% DSS by gastric lavage sequentially to establish CAC model. Group 2 was the model control; Group 3 to 5 received Vitamin D3 at 15, 30, 60IU/g/w before AOM/DSS treatment, while Group 6 (post-dose group) received 60IU/g/w VitD3 5 days after DSS intake. Mice were sacrificed after 14 weeks. Macroscopic and pathologic evaluations were carried out to assess the severity of CAC. The mRNA and protein levels of β-catenin were also detected. Results: The proliferation of SW480 cells was significantly inhibited by 1,25(OH)2D3 both dose-dependently and time-dependently (p<0.05). 1,25(OH)2D3 significantly decreased the transcriptional activity of β-catenin in SW480 cells by promoting the nuclear export of β-catenin (p<0.05) without affecting the mRNA and protein levels of β-catenin, which could be recovered by knocking down either FOXM1 or nVDR. In mice, Vitamin D intervention groups (G4,5,6) showed a lower tumor number and smaller tumor load than model control (G2) (p<0.05). However, there was no significant difference between the high dose group (G5) and post-dose group (G6). In addition, Vitamin D intervention groups presented lower β-catenin mRNA level than model control (p<0.05). The amount of nuclear β-catenin decreased as the VitD3 dose increased. Finally, the protein expression level of β-catenin was much less in the high dose group (G5) than model control (p<0.05). Conclusions: 1,25(OH)2D3 downregulates the transcriptional activity of β-catenin by expelling β-catenin out of nucleus and therefore severely dampens the proliferation of SW480 human colon cancer cells. In mice model, VitD3 treatment successfully inhibits the progression from AOM/DSS-induced colitis to colorectal cancer potentially by downregulating the activity of β-catenin signaling pathway.

Ang1 and Ang4 differentially affect colitis and carcinogenesis in an AOM-DSS mouse model

Olfactomedin-4 Deletion Exacerbates DSS-induced Colitis Through a Matrix Metalloproteinase-9-dependent Mechanism.

Angiopoietin and vascular endothelial growth factor expression in colorectal disease models

Mechanisms involved in biological behavior changes associated with Angptl4 expression in colon cancer cell lines.

Relationship between anti-tumor necrosis factor -α monoclonal antibody and chronic colitis in mice.

[Role of Integrin Α4β7 in the Pathogenesis of Ulcerative Colitis in Rats].

Crucial Involvement of Tumor-Associated Neutrophils in the Regulation of Chronic Colitis-Associated Carcinogenesis in Mice.

F4/80+Ly6Chigh Macrophages Lead to Cell Plasticity and Cancer Initiation in Colitis

S100A4 Promotes Colon Inflammation and Colitis-Associated Colon Tumorigenesis.

Blocking TNF-alpha in Mice Reduces Colorectal Carcinogenesis Associated with Chronic Colitis.

Expression of the Novel Adipokine C1qTNF-related Protein 4 (CTRP4) Suppresses Colitis and Colitis-Associated Colorectal Cancer in Mice

Alpha-1 Antitrypsin Inhibits Tumorigenesis and Progression of Colitis-Associated Colon Cancer through Suppression of Inflammatory Neutrophil-Activated Serine Proteases and IGFBP-3 Proteolysis

Activation of Angiogenin Expression in Macrophages by Lipopolysaccharide Via the TLR4/NF-κB Pathway in Colitis.

P099 IL-33 activates CD73-expressing cells promoting tumorigenesis during colitis-associated colorectal cancer

Different Susceptibilities between Apoe- and Ldlr-Deficient Mice to Inflammation-Associated Colorectal Carcinogenesis

Interleukin-34 deficiency aggravates development of colitis and colitis-associated cancer in mice

Activation of the Renin-Angiotensin System Promotes Colitis Development

P083 the Protective Role of Vitamin D3 on Colitis-Associated Colorectal Cancer in a Mouse Model

Influence of Cytotoxic T Lymphocyte Antigen-4 Monoclonal Antibody on Dextran Sulfate Sodium-Induced Colitis and Expression of Interleukin-17 Mrna in Mice

Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility

Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice